Verastem (VSTM) Interest Expenses (2017 - 2026)
Verastem's quarterly Interest Expenses came in at $382000.0 in Q1 2026, up 98.96% year-on-year from $192000.0 in Q1 2025, and down 7.95% quarter-over-quarter from $415000.0 in Q4 2025.
Verastem has reported Interest Expenses for 10 years, with the latest figure at $382000.0 in Q1 2026.
- For the quarter ending Q1 2026, Interest Expenses rose 98.96% year-over-year to $382000.0; the trailing twelve-month figure through Mar 2026 stood at $1.2 million (down 66.45% YoY), and the FY2025 full-year result was $1.1 million, down 75.05% from the prior year.
- Interest Expenses for Q1 2026 stood at $382000.0, down from $415000.0 in the prior quarter.
- The five-year high for Interest Expenses was $1.1 million in Q3 2024, with the low at $56000.0 in Q1 2022.
- Average Interest Expenses over 5 years is $720352.9, with a median of $724000.0 recorded in 2022.
- Peak annual rise in Interest Expenses reached 7140.0% in 2022, while the deepest fall reached 94.26% in 2022.
- Tracing VSTM's Interest Expenses over 5 years: stood at $724000.0 in 2022, then surged by 54.7% to $1.1 million in 2023, then increased by 2.32% to $1.1 million in 2024, then slumped by 63.79% to $415000.0 in 2025, then fell by 7.95% to $382000.0 in 2026.
- The last three Interest Expenses figures came in at $382000.0 (Q1 2026), $415000.0 (Q4 2025), and $319000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 22,854.00 |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | -5.50 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | 61,000.00 |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | -332,000.00 |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 12.90 Mn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 69.29 Mn |
| 10 | Verastem | 425.60 Mn | 243.93 Mn | 15.90 Mn | 382,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 382,000.00 |
| Mar 31, 2026 | 382,000.00 |
| Dec 31, 2025 | 415,000.00 |
| Dec 31, 2025 | 415,000.00 |
| Sep 30, 2025 | 319,000.00 |
| Sep 30, 2025 | 319,000.00 |
| Jun 30, 2025 | 100,000.00 |
| Jun 30, 2025 | 100,000.00 |
| Mar 31, 2025 | 192,000.00 |
| Mar 31, 2025 | 192,000.00 |
| Dec 31, 2024 | 1.15 Mn |
| Dec 31, 2024 | 1.15 Mn |
| Sep 30, 2024 | 1.15 Mn |
| Sep 30, 2024 | 1.15 Mn |
| Jun 30, 2024 | 1.14 Mn |
| Jun 30, 2024 | 1.14 Mn |
| Mar 31, 2024 | 1.13 Mn |
| Mar 31, 2024 | 1.13 Mn |
| Dec 31, 2023 | 1.12 Mn |
| Dec 31, 2023 | 1.12 Mn |
| Sep 30, 2023 | 1.13 Mn |
| Sep 30, 2023 | 1.13 Mn |
| Jun 30, 2023 | 1.12 Mn |
| Jun 30, 2023 | 1.12 Mn |
| Mar 31, 2023 | 769,000.00 |
| Mar 31, 2023 | 769,000.00 |
| Dec 31, 2022 | 724,000.00 |
| Dec 31, 2022 | 724,000.00 |
| Sep 30, 2022 | 717,000.00 |
| Sep 30, 2022 | 717,000.00 |
| Jun 30, 2022 | 640,000.00 |
| Jun 30, 2022 | 640,000.00 |
| Mar 31, 2022 | 56,000.00 |
| Mar 31, 2022 | 56,000.00 |
| Dec 31, 2021 | 10,000.00 |
| Dec 31, 2021 | 10,000.00 |
| Sep 30, 2021 | 7.98 Mn |
| Sep 30, 2021 | 7.98 Mn |
| Jun 30, 2021 | 1.01 Mn |
| Jun 30, 2021 | 1.01 Mn |
| Mar 31, 2021 | 975,000.00 |
| Mar 31, 2021 | 975,000.00 |
| Dec 31, 2020 | 1.35 Mn |
| Dec 31, 2020 | 1.35 Mn |
| Sep 30, 2020 | 1.90 Mn |
| Sep 30, 2020 | 1.90 Mn |
| Jun 30, 2020 | 1.87 Mn |
| Jun 30, 2020 | 1.87 Mn |
| Mar 31, 2020 | 10.67 Mn |
| Mar 31, 2020 | 10.67 Mn |
| Dec 31, 2019 | 5.45 Mn |
| Dec 31, 2019 | 5.45 Mn |
| Sep 30, 2019 | 5.04 Mn |
| Sep 30, 2019 | 5.04 Mn |
| Jun 30, 2019 | 5.19 Mn |
| Jun 30, 2019 | 5.19 Mn |
| Mar 31, 2019 | 4.93 Mn |
| Mar 31, 2019 | 4.93 Mn |
| Dec 31, 2018 | 3.95 Mn |
| Dec 31, 2018 | 3.95 Mn |
| Sep 30, 2018 | 862,000.00 |
| Sep 30, 2018 | 862,000.00 |
| Jun 30, 2018 | 516,000.00 |
| Jun 30, 2018 | 516,000.00 |
| Mar 31, 2018 | 480,000.00 |
| Mar 31, 2018 | 480,000.00 |
| Dec 31, 2017 | 328,000.00 |
| Dec 31, 2017 | 328,000.00 |
| Sep 30, 2017 | 110,000.00 |
| Sep 30, 2017 | 110,000.00 |
| Jun 30, 2017 | 109,000.00 |
| Jun 30, 2017 | 109,000.00 |
| Mar 31, 2017 | 12,000.00 |
| Mar 31, 2017 | 12,000.00 |